APA (7th ed.) Citation

Roach, K. M., & Bradding, P. (2020). Ca2+ signalling in fibroblasts and the therapeutic potential of KCa3.1 channel blockers in fibrotic diseases. British Journal of Pharmacology, 177(5), 1003. https://doi.org/10.1111/bph.14939

Chicago Style (17th ed.) Citation

Roach, Katy M., and Peter Bradding. "Ca2+ Signalling in Fibroblasts and the Therapeutic Potential of KCa3.1 Channel Blockers in Fibrotic Diseases." British Journal of Pharmacology 177, no. 5 (2020): 1003. https://doi.org/10.1111/bph.14939.

MLA (9th ed.) Citation

Roach, Katy M., and Peter Bradding. "Ca2+ Signalling in Fibroblasts and the Therapeutic Potential of KCa3.1 Channel Blockers in Fibrotic Diseases." British Journal of Pharmacology, vol. 177, no. 5, 2020, p. 1003, https://doi.org/10.1111/bph.14939.